BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rochoń J, Kalinowski P, Szymanek-Majchrzak K, Grąt M. Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease. World J Gastroenterol 2024; 30(23): 2964-2980 [PMID: 38946874 DOI: 10.3748/wjg.v30.i23.2964]
URL: https://www.wjgnet.com/2307-8960/full/v30/i23/2964.htm
Number Citing Articles
1
Li Lin, Shaowei Xiang, Yuan Chen, Yan Liu, Dingwen Shen, Xiaoping Yu, Zhe Wu, Yanling Sun, Kequan Chen, Jia Luo, Guilai Wei, Zhiguo Wang, Zhifeng Ning. Gut microbiota: Implications in pathogenesis and therapy to cardiovascular disease (Review)Experimental and Therapeutic Medicine 2024; 28(5) doi: 10.3892/etm.2024.12716
2
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
3
Chun-Han Cheng, Wen-Rui Hao, Tzu-Hurng Cheng. Role of intestinal glucagon-like peptide-1 in hypoglycemia response impairment in type 1 diabetesWorld Journal of Diabetes 2024; 15(11): 2237-2241 doi: 10.4239/wjd.v15.i11.2237